New CMDv guidance published on ‘partial MAH transfer’

3 June, 2016

A new guidance note has been issued by the CMDv, regarding so-called ‘partial MAH transfer’.  The document contains requirements and best practice recommendations to manage the situation where a product authorised via DCP or MRP has been transferred to another MAH in some, but not all, Member States (Link).

Business Units: 

Regulatory Outsourcing Options

Cyton’s dedicated regulatory procedures team can support you with:
 - Dossier preparation, submission & regulatory procedures
 - Regulatory intelligence and strategic planning
 - Life cycle management
 - Key person cover
 - Pharmacovigilance
 - Brexit support services